Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126436553 | 12643655 | 3 | F | 20160501 | 20160915 | 20160811 | 20160923 | EXP | FR-AMGEN-FRASP2016101657 | AMGEN | 10.00 | YR | C | M | Y | 41.00000 | KG | 20160922 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126436553 | 12643655 | 1 | PS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 7 MCG/KG, QWK | 826.622986 | UG/KG | Y | 125268 | 7 | UG/KG | POWDER FOR INJECTION | /wk | |||
126436553 | 12643655 | 2 | C | ELTROMBOPAG | ELTROMBOPAG | 1 | UNK | 0 | |||||||||||
126436553 | 12643655 | 3 | C | VINBLASTINE | VINBLASTINE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126436553 | 12643655 | 1 | Immune thrombocytopenic purpura |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126436553 | 12643655 | HO |
126436553 | 12643655 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126436553 | 12643655 | Drug ineffective | |
126436553 | 12643655 | Haemarthrosis | |
126436553 | 12643655 | Immune thrombocytopenic purpura |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126436553 | 12643655 | 1 | 20140201 | 20160625 | 0 |